<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03718962</url>
  </required_header>
  <id_info>
    <org_study_id>20180205R</org_study_id>
    <nct_id>NCT03718962</nct_id>
  </id_info>
  <brief_title>The Effect of UVB Phototherapy With Microneedling and Circled Needing in Vitiligo Patients</brief_title>
  <official_title>The Effect of UVB Phototherapy With Microneedling and Circled Needing in Vitiligo Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shin Kong Wu Ho-Su Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shin Kong Wu Ho-Su Memorial Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitiligo is a relatively common acquired disorder of pigmentation characterized by the
      development of well-defined white macules on the skin. Biopsies of lesional skin reveal a
      loss of epidermal melanocytes. Lesions may occur in a localized or generalized distribution
      and may coalesce into large, depigmented areas. Given the contrast between the white areas
      and normal skin, the disease is most disfiguring in darker skin types and has a profound
      impact on the quality of life of both children and adults . Patients with vitiligo often
      experience stigmatization, social isolation, and low self-esteem. The therapys include
      topical steroids, topical immunosuppresant, systemic steroids, phototherapy, and surgery.

      The aim of this study is to investigate the effect of phototherpy and accupuncture combined
      therapy for vitiligo patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 30, 2018</start_date>
  <completion_date type="Actual">January 30, 2020</completion_date>
  <primary_completion_date type="Actual">January 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>repigmentation</measure>
    <time_frame>12weeks</time_frame>
    <description>repigmentation amount</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Brief Description of Focus of Study Instead</condition>
  <arm_group>
    <arm_group_label>needling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>needling + phototherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>phototherapy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>phototherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Surrounding needling+ phototherapy</intervention_name>
    <description>Surrounding needling+ phototherapy</description>
    <arm_group_label>needling</arm_group_label>
    <other_name>phototherapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>phototherapy</intervention_name>
    <description>phototherapy</description>
    <arm_group_label>phototherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Clinical diagnosis of Vitiligo

        Exclusion Criteria:

          -  pregnancy

          -  immune disorder

          -  infection

          -  other dermatosis in treating areas
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>ShinKongHospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>October 23, 2018</study_first_submitted>
  <study_first_submitted_qc>October 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2018</study_first_posted>
  <last_update_submitted>February 5, 2020</last_update_submitted>
  <last_update_submitted_qc>February 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitiligo</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

